ZAI LAB LIMITED

ZLAB ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Revenue $100.5M $87.1M $65.8M $69.2M $68.9M $62.8M $62.6M $57.5M
Cost of Revenue $35.1M $33.6M $25.2M $25.5M $23.8M $21.3M $20.9M $20.0M
Gross Profit $65.4M $53.5M $40.6M $43.7M $45.1M $41.5M $41.7M $37.5M
Gross Margin 65.0% 61.4% 61.7% 63.2% 65.5% 66.0% 66.6% 65.2%
Operating Expenses
Research & Development $61.6M $54.6M $81.9M $58.8M $76.7M $48.5M $66.9M $99.5M
SG&A Expense $79.7M $69.2M $82.6M $68.6M $67.9M $62.5M $72.0M $66.6M
Operating Income $-76.1M $-70.3M $-124.0M $-83.6M $-89.5M $-69.5M $-97.3M $-128.6M
Operating Margin -75.7% -80.7% -188.3% -120.7% -130.0% -110.7% -155.4% -223.5%
Interest Expense $113.0K $0
Pretax Income $-80.3M $-53.5M $-95.4M $-69.2M $-120.9M $-49.1M $-62.0M $-161.2M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income $-80.3M $-53.5M $-95.4M $-69.2M $-120.9M $-49.1M $-61.8M $-161.2M
Net Margin -79.9% -61.4% -145.0% -99.9% -175.6% -78.3% -98.7% -280.1%
EPS (Basic) $-0.08 $-0.05 $-0.10 $-0.07 $-0.13 $-0.05 $-0.06 $-0.17
EPS (Diluted) $-0.08 $-0.05 $-0.10 $-0.07 $-0.13 $-0.05 $-0.06 $-0.17
Shares Outstanding (Basic) 975.9M 973.1M 966.4M 968.8M 964.8M 961.4M 958.1M 959.1M
Shares Outstanding (Diluted) 975.9M 973.1M 966.4M 968.8M 964.8M 961.4M 958.1M 959.1M
Dividends Per Share
← Newer Page 2 of 4 Older →